ArticleJournal of clinical medicine2021

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

Anna Jamroz-Wiśniewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.